NCT07034105 Spatiotemporal Gait Parameters of Healthy and Stroke Patients During Overground, Treadmill, and Body Weight Supported Treadmill Walking
| NCT ID | NCT07034105 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bangladesh University of Engineering and Technology |
| Condition | Gait Impairment in Stroke Patients |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2024-06-12 |
| Primary Completion | 2025-07-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2024-06-12 with a primary completion date of 2025-07-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Gait impairments following a stroke significantly hinder mobility and quality of life, emphasizing the need for precise assessment methods to guide effective rehabilitation strategies. This study evaluates the variability and reliability of spatiotemporal gait parameters across three walking modalities: overground walking, treadmill walking, and body-weight-supported treadmill walking. Using a counterbalanced design, all participants undergo gait analysis in each modality to ensure unbiased and reliable comparisons. The study also incorporates a locally developed, cost-effective Body Weight Support System (BWSS) to address the limitations of accessibility in resource-constrained settings. By identifying how different modalities influence gait variability and reliability, this research aims to optimize rehabilitation outcomes and demonstrate the feasibility of implementing affordable gait analysis tools in clinical practice.
Eligibility Criteria
Inclusion Criteria: * Participants must be between 18 to 75 years old. * More than 1- month post stroke patient. * Participants must be able to walk with or without assistance. * Patients including both the male and female. * Participants must be able to provide informed consent to participate in the study. Exclusion Criteria: * Severe cognitive or communicative disorders. * Significant joint malposition. * Psychological, cognitive dysfunction, and any other neuromuscular problem. * Pregnant women will be excluded to avoid any potential risks to the mother and fetus. * Unstable cardiovascular disease like congenital heart disease, deep vein thrombosis, coronary heart disease, previous history of heart attack or heart failure.
Contact & Investigator
Muhammad Tarik Arafat, PhD
PRINCIPAL INVESTIGATOR
Department of Biomedical Engineering, Bangladesh University of Engineering and Technology (BUET), Dhaka - 1205.
Frequently Asked Questions
Who can join the NCT07034105 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Gait Impairment in Stroke Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07034105 currently recruiting?
Yes, NCT07034105 is actively recruiting participants. Contact the research team at tarikarafat@bme.buet.ac.bd for enrollment information.
Where is the NCT07034105 trial being conducted?
This trial is being conducted at Dhaka, Bangladesh.
Who is sponsoring the NCT07034105 clinical trial?
NCT07034105 is sponsored by Bangladesh University of Engineering and Technology. The principal investigator is Muhammad Tarik Arafat, PhD at Department of Biomedical Engineering, Bangladesh University of Engineering and Technology (BUET), Dhaka - 1205.. The trial plans to enroll 25 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.